MDL | - |
---|---|
Molecular Weight | 770.73 |
Molecular Formula | C35H46O19 |
SMILES | OC1=C(O)C=CC(CCOC2C(C(OC3OC(C)C(O)C(O)C3O)C(OC(/C=C/C4=CC=C(O)C(O)=C4)=O)C(COC5OC(C)C(O)C(O)C5O)O2)O)=C1 |
Poliumoside, a caffeoylated phenylpropanoid glycoside, is isolated from Brandisia hancei stems and leaves. Poliumoside is an advanced glycation end product (AGE) formation and rat lens aldose reductase ( RLAR ) inhibitor, with IC 50 s of 19.69 and 8.47 μM, respectively. Poliumoside also has antiinflammatory and antioxidant activity [1] [2] [3] .
IC50: 8.47 μM (aldose reductase) [1]
Poliumoside inhibits AGE formation and RLAR, with IC
50
s of 19.69, and 8.47 μM, respectively
[1]
.
Poliumoside (5-30 μM; 3 h) inhibits AAPH-induced hemolysis of rat red blood cells in vitro
[2]
.
Poliumoside (12.5-100 μM; pretreated 2 h) inhibits the release of TNF-α and IL-6 in LPS-induced RAW 264.7 cells
[3]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Poliumoside inhibits vessel dilation in larval zebrafish [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 100 mg/mL ( 129.75 mM ; Need ultrasonic)
Ethanol : 50 mg/mL ( 64.87 mM ; Need ultrasonic)
H 2 O : 50 mg/mL ( 64.87 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.2975 mL | 6.4874 mL | 12.9747 mL |
5 mM | 0.2595 mL | 1.2975 mL | 2.5949 mL |
10 mM | 0.1297 mL | 0.6487 mL | 1.2975 mL |